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Effects of chlorpropamide on loop of Henle function and plasma renin.
We have suggested that Inhibition of renin release by sodium chloride is
related to increased absorptive solute transport in the loop of Henle. Tn
the rat, we have shown that reduced chloride transport in the loop is
associated with increased renin release. Based on indirect evidence, it
has been suggested that chlorpropamide (CPMD) increases loop solute
transport. This study directly evaluates the effect of CPMD on loop
chloride transport and plasma renin activity (PRA) in the male Sprague—
Dawley rat. Loop of Henle chloride reabsorption (measured by recol-
lection mieropuncture) and PRA were determined before and after
acute infusion of CPMD (N 8) or vehicle (N = 8). Although delivery
to the loop was not significantly changed, CPMD increased (P < 0.05)
absolute loop chloride reabsorption from 1798 pEq/min 200 5E to 2453
pEq/min 206 SE. PRA was decreased (P < 0.01) from 9.2 ng/ml/hr
1.0 Sr to 5.6 ng/ml/hr 0.8 5E following CPMD infusion. Comparable
vehicle infusion did not alter loop chloride reabsorption or PRA.
Arterial pressure, and whole kidney and single nephron glomerular
filtration rates were unchanged following infusion of CPMD or vehicle.
These results demonstrate that an increase in 1oop chloride reabsorp-
tion is associated with a decrease in renin release. This observation is
consistent with the hypothesis that renin release is inversely related to
the magnitude of chloride transport in the thick ascending limb of the
loop of Henle.
The control of renin release is the result of the interaction of
sympathetic nerves, a renal vascular receptor, and a renal
tubular receptor [II. Sodium chloride loading suppresses renin
release, primarily by a renal tubular mechanism 121, and we
have suggested that inhibition of renin secretion by sodium
chloride is specifically related to a renal tubular effect of
chloride. In the sodium chloride—deprived rat, acute and
chronic administration of sodium without chloride fails to
inhibit renin release, whereas renin release is suppressed by
chloride loading without sodium [3, 41. Furthermore, we have
demonstrated that absorptive chloride transport in the loop of
Henle is decreased and renin release is increased in the adre-
nalectomized rat [51; dexamethasone replacement normalized
both loop chloride reabsorption and plasma renin. Increased
renin release in the potassium depleted rat is also associated
with impaired solute transport in the loop of Henle [6—91. Based
on these observations, we have suggested that renin release is
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inversely related to the magnitude of absorptive chloride trans-
port in the thick ascending limb of the loop of Henle (TALH).
Based on indirect evidence, it has been suggested that the
sulfonylurea, chlorpropamide increases solute transport in the
loop of Henle. In rats with hereditary diabetes insipidus (Brat-
lieboro rat), Kusano et al have recently reported that chlorprop-
amide increases the corticopapillary sodium gradient and stim-
ulates sodium chloride transport—coupled oxidation of substrate
in the medullary TALH [101. Thus, we hypothesize that
chlorpropamide would decrease renin release. Indeed, acute
administration of chlorpropamide has been reported to lower
plasma renin activity in the sodium chloride—deprived rat [11].
The purpose of the present study was to directly measure loop
chloride reabsorption and plasma renin activity (PRA) in the
rat, before and after acute intravenous infusion of chlorprop-
amide.
Methods
PRA and renal function were measured in mactin anesthe-
tized (100 mg/kg body wt) male Sprague—Dawley rats before
and after infusion of either ehlorpropamide (N 8) or saline
vehicle (N = 8). Preparative surgery included placement of two
jugular catheters (PE-50), one for constant infusion of inulin (a
2.5% solution delivered in 0.9% NaCI at 0.5 ml/hr/100 g body
wt) and the other for administration of chlorpropamide or
vehicle. A femoral arterial catheter (PE-50) was inserted for
blood collections and constant monitoring of arterial pressure.
The left kidney was exposed by a lateral incision, and prepared
for micropuncture by mounting it in a lucite holder and packing
it with cotton to reduce movement. The kidney was maintained
under an oil bath. The left ureter was catheterized for urine
collections. A bladder catheter was inserted to collect urine
from the right kidney. To account for surgical blood losses and
for measurement of inulin clearance, animals received a 1.2 ml
bolus injection of inulin—saline after completion of surgery and
before beginning the inulin infusion.
After completion of preparative surgery, a 45-minute recov-
ery period was allowed. During this time, a suitable area of the
left kidney's surface was visualized under a binocular micro-
scope and illuminated with a fiberoptic light. During a 30 to 50
minute control period before chlorpropamide or vehicle infu-
sion, three proximal and three distal tubules were marked, and
timed fluid collections were made following insertion of sudan
black—stained castor oil blocks immediately distal to each of the
puncture sites. Distal tubules were identified by systemic injec-
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tion of 50 to 100 pi of 2% FDC green dye. Thus, the "ioop
segment" (the nephron segment between the two collection
sites) included a portion of the late proximal tubule and a
segment of the early distal tubule, including the macula densa.
For each animal, values from the proximal collections and distal
collections were averaged and a single proximal value and a
single distal value were reported. Peripheral venous blood (600
d) was obtained at the end of the control period. Chlorprop-
amide was made up in 0.9% NaCI to a final concentration of 50
mg/mi and infused (20 mg/l00 g body wt) over a five minute
period. This dose was based on a previously reported chronic
dosage in the rat that did not produce severe hypoglycemia [11].
Control animals received a comparable volume of 0.9% NaCl
(1.2 ml) over five minutes. During a subsequent 30 to 45 minute
post-infusion period, re-collections were obtained from the
same proximal and distal tubules punctured before infusion.
For measurement of blood chemistries, peripheral arterial
blood was obtained at the end of the micropuncture collection
periods, before and after infusion of vehicle or chlorpropamide.
Blood was obtained midway through the collections for mea-
surement of plasma inulin concentration.
The following measurements were obtained before and after
chlorpropamide or vehicle infusion: direct arterial pressure;
arterial hematocrit; serum glucose; whole kidney and single
nephron glomerular filtration rate (GFR); whole kidney sodium,
potassium and chloride excretion; proximal and distal tubule
fluid flow and chloride concentrations; and PRA. In addition,
plasma sodium, potassium, and chloride concentrations were
measured in blood obtained at the end of the experiment.
Plasma and urine sodium and potassium concentrations were
measured with a flame photometer (Instrumentation Labora-
tory, Morris Plains, New Jersey, USA) and chloride was
measured with a Buchler chloridometer. Plasma and urine
inulin concentrations were measured with the anthrone method
[12]. Inulin was measured in tubular fluid by a microflurometric
method [13]. Glucose was measured by glucose oxidase cal-
orimetry. PRA was measured by radioimmunoassay for angio-
tensin I [14] using standards, antibody, and labelled angiotensin
I purchased from New England Nuclear Corporation (Boston,
Massachusetts, USA).
Chloride was measured in tubular fluid samples with a
double—barreled microelectrode containing a chloride specific
resin (chloride micro exchanger, #477913, Corning Glass
Works, Medfield, Massachusetts, USA), according to the
method described by Oberleithner, Guggino and Giebisch [15].
After collection, tubular fluid samples were transferred into an
oil column at one end of a constant bore microcap. The volume
was determined with a Gaetner slide comparator, and then the
chloride concentration was measured with the double—barrelled
microelectrode. The tip of the electrode was advanced through
the oil into the sample, and the voltage was recorded. One side
of the electrode was filled with 0.5 M K2S04 to serve as the
reference solution; the other side contained the resin in the tip
and was backfilled with 0.15 M NaC1 to serve as the ion—selec-
tive barrel. The electrode was connected by a silver wire in the
reference side, and a silver—silver chloride pellet in the
ion—selective side was attached to a Kiethly electrometer. The
output of the electrometer was digitized on a Fluke Multimeter.
Standard solutions of 15 and 150 mEq/liter of NaCl in double
distilled water were used to standardize the electrode before
each tubular fluid sample was measured. The tip of the elec-
trode was inserted into doubled distilled water between each
measurement. Any electrode with a tip resistance greater than
1011 ohm or less than iø ohm, or a sensitivity of less than 50
mV difference between the two standard solutions was rejected.
To evaluate reproducibility, 20 measurements were obtained in
separate aliquots of each of two solutions (treated as unknowns)
that contained 50 pEq/nl and 100 pEq/nl of chloride, respec-
tively, as determined by flame photometry. The respective
results were as follows: a) mean, 49.36 pEq/nl 2.97 SD
(coefficient of variation, 6.0%); b) mean, 97.0 pEq/nl 5.05 SD
(coefficient of variation, 5.2%). To evaluate selectivity of the
resin, measurements were obtained with a number of different
substances. The resin failed to respond appreciably to several
concentrations of each of the following (highest concentration
noted in parentheses): a) bicarbonate (150 mM); sulfate (150
mM); albumin (6%); urea (6%). The selectivity of chloride/bi-
carbonate is reportedly 10:1 [15]. However, our measured
selectivity of all the above was greater than 10:1.
Loop chloride reabsorption was calculated as proximal fluid
flow times proximal chloride concentration, minus distal fluid
flow times distal chloride concentration. Proximal tubule chlo-
ride reabsorption was calculated by the difference between
filtered load of chloride and chloride delivery to the late
proximal tubule.
The Student's 1-test was used to determine statistical signif-
icance. Measurements before and after infusion were compared
by a paired 1-test and measurements between the two groups
with an unpaired t-test. Results are presented as mean SE.
Results
Mean body weights of control (311 g 17 SE) and chlorprop-
amide treated rats (319 g 13 SE) did not differ. Mean arterial
pressure, heart rate, hematocrit and whole kidney GFR also did
not differ between control and experimental animals and were
not affected by infusion of chlorpropamide or vehicle (Table 1).
Plasma glucose concentration decreased (P < 0.01) in chlor-
propamide—treated, but not in control animals. Urinary excre-
tion of sodium, potassium, and chloride increased (P < 0.05) in
both groups; however, after acute infusion, excretion of all
three electrolytes was greater (P < 0.05) in the chlorprop-
amide—infused than in the control group. Comparing control
and chlorpropamide infused animals, at the end of the experi-
ment there were no differences of serum sodium (142 mEq/liter
1 vs. 144 mEq/liter 1), potassium (4.9 mEq/liter 0.2 vs.
4.6 mEq/liter 0.3), or chloride (107 mEq/liter 2 vs. 109
mEq/liter 1) concentrations.
Single nephron GFR, determined from both proximal and
distal collection sites, did not differ between groups and was not
affected by acute infusion of chlorpropamide or vehicle (Table
2). In addition, SNGFR determined from proximal and distal
sites were not different from each other. Before infusion,
tubular fluid to plasma ratios (TF/P) of inulin were not different
between groups and were not altered by acute infusion. After
infusion, TF/P inulin tended to be higher in animals receiving
chlorpropamide than in controls, although this difference was
not statistically significant.
Filtered chloride load, chloride concentration in late proximal
tubular fluid, absolute and fractional proximal tubular reabsorp-
tion of chloride, and chloride delivery to the loop of Henle did
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Table 1. Effects of chiorpropamide (CPMD) or vehicle control on arterial pressure, hematocrit, plasma glucose, whole kidney GFR, and
urinary electrolyte excretion
Control
(N=8)
CPMD
(N=8)
Pre Post Pre Post
BPmmHg
Heart rate beats/mm
Hct %
Glucose mg/dl
GFR mI/mm
UNaV p.Eq/min
UKV p.Eq/min
UV p.Eq/min
108±4
340 15
45.6 1.0
114 6
1.938 0.213
0.26 0.53
1.23 0.18
1.07 0.24
107±4
327 15
45.0 1.1
108 6
1.962 0.268
0.57 0•18L'
1.60 011b
2.15 o46b
108±6
338 6
46.0 1.0
122 5
2.139 0.128
0.28 0.04
1.56 0.29
0.92 0.20
112
328
45.8
78
2.279
3.29
2.40
4.34
11
1.04'
0.252
083o,b
036a.b
,05a,b
P < 0.05 compared to control group
b P < 0.05 compared to pre-infusion
Table 2. Single nephron GFR and TF/P inulin, determined in proximal and distal tubular fluid, before and after infusion of chiorpropamide
(CPMD) or vehicle
Pre-prox Pre-dist Post-prox Post-dist
SNGFR ni/mm
CPMD 36.5 4.2 34.2 4.7 40.3 6.5 46.8 5.2
Control 34.0 3.1 37.9 3.7 37.2 4.1 43.6 3.6
TF/P Inulin
CPMD 2.04 0.17 4.32 0.45 1.98 0.15 4.89 0.62
Control 1.72 0.23 4.02 0.43 1.75 0.26 3.75 0.52
Table 3. Effect of chlorpropamide (CPMD) or vehicle control on chloride delivery and reabsorption
Control CPMD
Pre Post Pre Post
Filtered Cl 3712 295 3920 329 4187 366 4339 385
pEqimin
Late proximal 120 5 119 6 123 6 125 7
CF cone
pEq/nl
Prox CF reabsorption 1162 385 1354 259 1663 322 1457 250
Absolute
pEq/min
Fractional 31 5 34 4 37 5 30 4
%
Loop delivery 2464 176 2566 259 2536 127 2905 278
pEqimin
Early distal 43 4 40 5 51 3 38 2'
CF cone
pEqini
Loop CF reabsorption 1915 166 1771 I41 1798 200 2453 206a,b
Absolute
pEq/min
Fractional 75 6 72 4 71 6 79 2
%
Distal delivery 584 125 617 148 724 152 592 91
pEqimin
a P < 0.05 compared to post-infusion value in control animals
b p < 0.02 compared to pre-infusion value CPMD group
not differ between groups and were not changed by acute was greater in animals infused with chlorpropamide than in
infusion of chlorpropamide or vehicle (Table 3). Loop chloride vehicle infused controls (P < 0.02). Fractional loop chloride
reabsorption increased significantly (P < 0.05) following reabsorption also tended to increase in response to chlorprop-
chiorpropamide infusion ( = 655 pEq/min 256 SE), but did amide infusion, although this change was not statistically sig-
not change significantly with vehicle infusion ( = —139 nificant. Chloride concentrations in early distal tubular fluid did
pEq/min 209 SE). After infusion, loop chloride reabsorption not differ in control or chloq,ropamide treated animals. How-
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rate limiting for sodium chloride cotransport in this nephron
16 segment [16, 17].
14 Acute hypoglycemia stimulates renin release via a neural
12 mechanism [18], and it has recently been reported that low
10 frequency renal nerve stimulation increases absorptive trans-c port of sodium and chloride in the loop of Henle [19]. However,8 in the present study, it is unlikely that the modest reduction of
6 plasma glucose by chlorpropamide was sufficient to stimulate
4 sympathetic nervous system activity. Blood pressure and heart
2 rate did not increase, and PRA decreased. Consequently, it is
unlikely that the chlorpropamide induced increase of chloride
transport in the loop and reduction of PRA are related to
increased neural activity.
Based on the close anatomic association between the macula
densa and the renin secreting cells of the renal afferent arteriole,
it is generally assumed that the renal tubular signal for renin
release is transmitted by the macula densa. Unfortunately, the
macula densa is not accessible to micropuncture and we can
only speculate about events that occur in that nephron segment.
Most evidence suggests that the macula densa is part of the
TALH, and chloride is actively transported at sites both prox-
imal and distal to the macula densa [16, 17, 20—23]. Conse-
quently, transport at the macula densa and the TALH may be
similar. Alternatively, we cannot exclude the possibility that
the signal to the macula densa may not be loop transport per se,
but rather sodium chloride delivery to the macula densa as
modified by transport in the TALH. In a series of retrograde
microperfusion studies in the rat, Thurau et a! have reported
that increased chloride delivery to the macula densa "acti-
vates" the tissue content of single nephron renin [24]. How-
ever, activation of tissue renin is not equivalent to renin
secretion. Furthermore, in response to saline infusion, renin
release is decreased, and despite increased absorptive chloride
transport in the loop, chloride delivery to the early distal tubule
is increased [5]. Thus, it is unlikely that renin release is
inhibited by decreased chloride delivery to the macula densa as
a consequence of increased absorptive transport proximal to
that site. It is also possible that the renal tubular signal for renin
release is not dependent on events at the macula densa.
Electron microscopic evidence in the rat suggests that the
TALH itself makes contact with the renal afferent arteriole and
presumably renin secreting cells [25]. Thus, there may be a
direct association between loop transport and renin release,
unrelated to the macula densa.
Chlorpropamide does not directly stimulate ADH release
[26—28]. However, in the water loaded state, chiorpropamide
produces antidiuresis in normal man, in most patients with
diabetes insipidus, and in the experimental animal [26, 29]. Our
micropuncture study demonstrating that chlorpropamide in-
creases absorptive chloride transport in the loop of Henle
confirms earlier indirect evidence for this effect of chlorprop-
amide on loop function in the Brattleboro rat [10]. Assuming
that chlorpropamide has a similar effect in medullary nephrons,
these results suggest that chlorpropamide augments the effects
of ADH by increasing the medullary concentrating gradient due
to increased solute transport in the TALH. Consistent with
previous reports [30], we also observed that acute chlorprop-
amide administration resulted in increased urinary excretion of
sodium and chloride. Because chloride delivery to the early
distal tubule was not increased in chlorpropamide treated
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Fig. 1. Effect of chiorpropamide on ioop of Henle chloride reabsorp-
tion and plasma renin activity. Symbols are: (---i) CPMD; (—•)
control; (*) P < 0.01 compared to pre-infusion value; (**) P < 0.05
compared to pre-infusion value.
ever, early distal, tubular fluid chloride concentration was
significantly decreased (P < 0.01) after chlorpropamide infusion( = —13.4 pEq/ml 3.6 SE). Distal tubular fluid chloride
concentrations did not change significantly in the control group.
Before infusion, PRA did not differ between groups. PRA
was suppressed (9.5 ng/ml/hr 1.0 SE to 5.6 ng!mllhr 0.8 SE;
P < 0.01) following chlorpropamide infusion (Fig. 1), whereas
infusion of vehicle did not change PRA (9.2 nglml/hr 2.4 SE to
9.2 ng/ml/hr 2.4 SE). After infusion, PRA was lower in
chlorpropamide infused than in vehicle infused animals (P <
0.01). Figure 1 emphasizes the association between the
chlorpropamide induced increase of absorptive chloride trans-
port in the loop and the decrease of PRA; loop chloride
transport and PRA were not altered in control animals.
In the absence of changes of arterial pressure, plasma volume
(estimated by acute changes in arterial hematocrit), whole
kidney GFR, single nephron GFR, or chloride delivery to the
loop, acute infusion of chlorpropamide increased chloride re-
absorption in the loop of Henle and decreased PRA. In con-
trast, infusion of vehicle had no effect on loop chloride reab-
sorption or PRA.
Chloride is actively transported in the thick ascending limb of
the loop of Henle [16, 17]. We have previously demonstrated an
association between decreased loop chloride reabsorption and
increased plasma renin concentration in saline—drinking adre-
nalectomized rats [5]. We have also shown that acute saline
infusion in the normal rat results in increases of GFR, chloride
delivery to the loop, chloride reabsorption, and a decrease of
plasma renin [5]. The present study demonstrates that reduced
PRA is associated with an increase in intrinsic ioop chloride
reabsorption, without an increase in GFR or chloride delivery
to the loop. These results support the hypothesis that the
magnitude of chloride transport in the TALH is the renal
tubular signal that controls renin release. Although we did not
measure sodium reabsorption, recent evidence suggests that
sodium and chloride are cotransported in the TALH. Because
of the relatively high affinity of the cotransport system for
sodium compared to chloride, chloride rather than sodium is
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animals, this effect of chlorpropamide on electrolyte excretion
presumably occurs at a more distal site in the nephron. Alter-
natively, chlorpropamide may have caused a redistribution of
blood flow, and our measurements in superficial nephrons may
not represent overall electrolyte excretion rate. However, the
relationship of single nephron UFR to whole kidney GFR did
not change following chlorpropamide infusion, suggesting that
redistribution of blood flow did not occur. Nevertheless, we
cannot exclude the possibility that transport in deep and super-
ficial nephrons may differ.
In summary, we have previously demonstrated that increased
renin release is associated with reduced chloride transport in
the loop segment [5]. In this present study, acute chlorprop-
amide infusion increased chloride reabsorption in the loop of
Henle segment and suppressed PRA without altering arterial
pressure, plasma volume, glomerular filtration rate, or chloride
delivery to the loop. These results are consistent with the
hypothesis that renin release is inversely related to the magni-
tude of chloride transport in the TALH.
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